Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRRO
#3224
Korro Bio, Inc. Common Stock
12.130
0
+4.39%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+4.39%
Monatliche Änderung
+6.22%
6 month change
-68.82%
Jahresänderung
-68.82%
Vorheriger Schlusskurs
11.620
0
Open
12.130
0
Bid
Ask
Low
12.130
0
High
12.130
0
Volumen
27
Märkte
Aktien
Gesundheitswesen
KRRO
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
34.18 M
34.98 M
35.29 M
8.02 M
9.39 M
—
Valuation ratios
Enterprise value
—
—
—
228.05 M
301.79 M
911.66 M
Price to earnings ratio
—
—
—
-0.93
-4.06
-12.29
Price to sales ratio
—
—
—
—
149.54
—
Price to cash flow ratio
—
—
—
1.12
5.65
16.48
Price to book ratio
—
—
—
0.14
0.49
0.74
Enterprise value to EBITDA ratio
—
—
—
-2.81
—
—
Profitability ratios
Return on assets %
0.1
0.46
0.67
0.37
0.37
0.46
Return on equity %
0.14
0.65
1.18
0.48
0.52
0.71
Return on invested capital %
-211.02
-626.33
-671.01
-699.18
-487.96
-380.89
Gross margin %
100
100
—
—
100
400
Operating margin %
-74.49
-597.32
—
—
-4 047.12
-5 623.72
EBITDA margin %
—
—
—
—
—
—
Net margin %
71.68
601.98
—
—
3 680.36
5 272.64
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.45
11.79
4.16
8.87
8.79
30.89
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.15
0.06
0
0
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.06
0.08
0.03
—
—
—
Long term debt to total equity ratio
0.04
0.03
0.01
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
44
6.73
7.32
EBIT per share
—
—
—
-55.28
—
—
EBITDA per share
—
—
—
-52.97
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
108.64
14.14
38.6
Net current asset value per share
—
—
—
112.94
14.74
49.06
Tangible book value per share
—
—
—
350.43
77.75
315.52
Working capital per share
—
—
—
100.2
13.07
42.62
Book value per share
—
—
—
350.43
77.75
315.52
Nachrichten
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Clear Street因高氨血症项目潜力上调Korro Bio股票评级
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?
H.C. Wainwright将Korro Bio股票评级上调至"买入",看好新药潜力
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential
派珀·桑德勒上调Korro Bio评级至增持,看好UCD疗法
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential
Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28
William Blair重申Korro Bio股票市场表现评级
雷蒙德詹姆斯维持Korro Bio股票"市场表现"评级